Aytu Biopharma Inc expected to post a loss of 32 cents a share — Earnings Preview
Aytu Biopharma Inc is expected to show a fall in quarterly revenue when it reports results on September 22 for the period ending June 30 2026 The Denver Colorado-based company is expected to report a 18.9% decrease in revenue to $12.276 million from $15.14 million a year ago, according to the mean estimate from 3 analy